E-LIB Suche - Ergebnisse für: Mrak, Daniel

1

Impact of muscle biopsy on the clinical decision-making pro..:

Kastrati, Kastriot ; Nakhost Lotfi, Nasim ; Tawfik, Marwa G....
Journal of Autoimmunity. 144 (2024) - p. 103185 , 2024

Link: https://doi.org/10.1016/..

2

FAPi PET/CT for assessment and visualisation of active myos..:

Kastrati, Kastriot ; Nakuz, Thomas S. ; Kulterer, Oana C....
eClinicalMedicine. 72 (2024) - p. 102598 , 2024

Link: https://doi.org/10.1016/..

3

Accelerated waning of immune responses to a third COVID-19 ..:

Mrak, Daniel ; Kartnig, Felix ; Sieghart, Daniela...
Journal of Autoimmunity. 135 (2023) - p. 102981 , 2023

Link: https://doi.org/10.1016/..

4

Heterologous vector versus homologous mRNA COVID-19 booster..:

Mrak, Daniel ; Sieghart, Daniela ; Simader, Elisabeth...
Nature Communications. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

5

Multiparametric Prediction Models for Coronavirus Disease 2..:

Sieghart, Daniela ; Hana, Claudia A ; Haslacher, Helmuth...
Clinical Infectious Diseases. 76 (2022) 5 - p. 816-823 , 2022

Link: https://doi.org/10.1093/..

6

Lipoprotein (a) and long-term outcome in patients with peri..:

Zierfuss, Bernhard ; Höbaus, Clemens ; Feldscher, Anna...
Atherosclerosis. 363 (2022) - p. 94-101 , 2022

Link: https://doi.org/10.1016/..

7

Reactogenicity and immunogenicity of the second COVID-19 va..:

Göschl, Lisa ; Mrak, Daniel ; Grabmeier-Pfistershammer, Katharina...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

8

GlycA for long-term outcome in T2DM secondary prevention:

Zierfuss, Bernhard ; Höbaus, Clemens ; Herz, Carsten T....
Diabetes Research and Clinical Practice. 171 (2021) - p. 108583 , 2021

Link: https://doi.org/10.1016/..

9

Evaluation of sCD163 and sTWEAK in patients with stable per..:

Mrak, Daniel ; Zierfuss, Bernhard ; Höbaus, Clemens...
Atherosclerosis. 317 (2021) - p. 41-46 , 2021

Link: https://doi.org/10.1016/..

10

Journal of Autoimmunity / Accelerated waning of immune resp..:

Bonelli, Michael ; Heinz, Leonhard X ; Mrak, Daniel...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-64332/128. , 2023

Link: https://doi.org/10.1016/..

11

Heterologous vector versus homologous mRNA COVID-19 booster..:

Mrak, Daniel ; Sieghart, Daniela ; Simader, Elisabeth...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467419/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Reactogenicity and immunogenicity of the second COVID-19 va..:

Göschl, Lisa ; Mrak, Daniel ; Grabmeier-Pfistershammer, Katharina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515892/. , 2022

Link: http://www.ncbi.nlm.nih...

13

Atherosclerosis / Lipoprotein (a) and long-term outcome in ..:

Schernthaner, Gerit-Holger ; Zierfuss, Bernhard ; Höbaus, Clemens...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-63570/128. , 2022

Link: https://doi.org/10.1016/..

14

INVITED LECTURES / ORAL COMMUNICATIONS Additional heterolog..:

Bonelli, Michael ; Mrak, Daniel ; Tobudic, Selma...
info:eu-repo/semantics/altIdentifier/doi/10.33004//reumatizam-supp-68-1-3. , 2021

Link: https://hrcak.srce.hr/30..

15

Diabetes Research and Clinical Practice / GlycA for long-te..:

Schernthaner, Gerit-Holger ; Zierfuss, Bernhard ; Höbaus, Clemens...
vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-34166/128. , 2021

Link: https://resolver.obvsg.a..